Pre-excitation on the electrocardiogram: what next?

Ventricular pre-excitation, or a delta wave, on the electrocardiogram in an asymptomatic individual is frequently encountered in clinical practice. Management remains challenging and practice currently varies. This article reviews the evidence and suggests an approach to such patients.

[1]  J. Svendsen,et al.  Current strategy for treatment of patients with Wolff-Parkinson-White syndrome and asymptomatic preexcitation in Europe: European Heart Rhythm Association survey. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[2]  J. Triedman,et al.  PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm So , 2012, Heart rhythm.

[3]  D. Massel,et al.  Risk of Arrhythmia and Sudden Death in Patients With Asymptomatic Preexcitation: A Meta-Analysis , 2012, Circulation.

[4]  D. Milan,et al.  Catecholamine challenge unmasking high-risk features in the Wolff-Parkinson-White syndrome. , 2009, Europace.

[5]  J. Triedman Management of asymptomatic Wolff–Parkinson–White syndrome , 2009, Heart.

[6]  A. Skanes,et al.  WPW pattern in the asymptomatic individual: has anything changed? , 2009, Circulation. Arrhythmia and electrophysiology.

[7]  V. Santinelli,et al.  The natural history of asymptomatic ventricular pre-excitation a long-term prospective follow-up study of 184 asymptomatic children. , 2009, Journal of the American College of Cardiology.

[8]  B. Maron,et al.  Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations revisited a comparison of U.S. and European criteria for eligibility and disqualification of competitive athletes with cardiovascular abnormalities. , 2008, Journal of the American College of Cardiology.

[9]  C. Wren,et al.  Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. , 2005, European heart journal.

[10]  V. Santinelli,et al.  Radiofrequency ablation in children with asymptomatic Wolff-Parkinson-White syndrome. , 2004, The New England journal of medicine.

[11]  V. Santinelli,et al.  A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome. , 2003, The New England journal of medicine.

[12]  Silvia G Priori,et al.  ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Co , 2003, Circulation.

[13]  H. Calkins,et al.  NASPE Policy Statement on Catheter Ablation: , 2003, Pacing and clinical electrophysiology : PACE.

[14]  O. Alfieri,et al.  Usefulness of invasive electrophysiologic testing to stratify the risk of arrhythmic events in asymptomatic patients with Wolff-Parkinson-White pattern: results from a large prospective long-term follow-up study. , 2003, Journal of the American College of Cardiology.

[15]  H. Calkins,et al.  NASPE Expert Consensus Conference: Radiofrequency Catheter Ablation in Children with and without Congenital Heart Disease. Report of the Writing Committee , 2002, Pacing and clinical electrophysiology : PACE.

[16]  G. V. Van Hare,et al.  Use of electrophysiologic testing to assess risk in children with Wolff-Parkinson-White syndrome , 2002, Cardiology in the Young.

[17]  P. Fitzsimmons,et al.  The natural history of Wolff-Parkinson-White syndrome in 228 military aviators: a long-term follow-up of 22 years. , 2001, American heart journal.

[18]  A. Pietersen,et al.  Atrial fibrillation in the Wolff-Parkinson-White syndrome. , 1992, The American journal of cardiology.

[19]  F. Gaita,et al.  Stress and pharmacologic tests as methods to identify patients with Wolff-Parkinson-White syndrome at risk of sudden death. , 1989, The American journal of cardiology.

[20]  J. F. Keane,et al.  Wolff-Parkinson-White syndrome and supraventricular tachycardia during infancy: management and follow-up. , 1985, Journal of the American College of Cardiology.

[21]  L. Dreifus,et al.  Ventricular Fibrillation: A Possible Mechanism of Sudden Death in Patients with Wolff‐Parkinson‐White Syndrome , 1971, Circulation.